Advertisement

Cytogenetic and immunohistochemical characterization of mammary analogue secretory carcinoma of salivary glands

      Objectives

      Mammary analogue secretory carcinoma (MASC), initially considered a subset of acinic cell carcinoma (ACC), harbors an ETV6 translocation [t(12:15)(p13:25 q)] and is now regarded as a distinct entity. Several putative markers to differentiate MASC from ACC have been reported; however, the immunohistochemical profile is still being explored and updated. The purpose of this study was to further explore the cytogenetic and immunohistochemical profile of MASC.

      Study Design

      Cases were analyzed for ETV6 translocation using fluorescent in situ hybridization and stained for CK8, amylase, mammaglobin, GCDFP-15, MUC1, MUC4, STAT5a, Ki-67 (n = 37), CK7, Cam5.2, CK14, SMA, p63, S100, vimentin and DOG1 (n = 42). Histochemical stains for mucins were also performed and data collected for age, sex, and site.

      Results

      Fluorescent in situ hybridization showed 9 cases with ETV6 rearrangement and 2 with increased ETV6 copies. These 11 cases showed an absence of PAS-D–resistant granules, with 10 of 11 showing strong S100, mammaglobin, and STAT5a staining. All ACCs showed diffuse DOG1 staining, whereas 8/11 MASCs were negative and 3 showed only focal DOG1 staining.

      Conclusion

      DOG1 can be used in conjunction with PAS-D, S100, and mammaglobin to identify MASCs. Cases with increased ETV6 copies are a novel finding with a similar immunostaining profile and should be considered as MASCs.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      References

        • Skálová A.
        • Vanecek T.
        • Sima R.
        • et al.
        Mammary analogue secretory carcinoma of salivary glands containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity.
        Am J Surg Pathol. 2010; 34: 599-608
        • Sethi R.
        • Kozin E.
        • Remenschneider A.
        • et al.
        Mammary analogue secretory carcinoma: update on a new diagnosis of salivary gland malignancy.
        Laryngoscope. 2014; 124: 188-195
        • Hirokawa M.
        • Sugihara K.
        • Sai T.
        • et al.
        Secretory carcinoma of the breast: a tumour analogous to salivary gland acinic cell carcinoma?.
        Histopathology. 2002; 40: 223-229
        • Lei Y.
        • Chiosea S.I.
        Re-evaluating historic cohort of salivary acinic cell carcinoma with new diagnostic tools.
        Head Neck Pathol. 2012; 6: 166-170
        • Chiosea S.I.
        • Griffith C.
        • Assaad A.
        • et al.
        The profile of acinic cell carcinoma after recognition of mammary analog secretory carcinoma.
        Am J Surg Pathol. 2012; 36: 343-350
        • Shah A.A.
        • Wenig B.M.
        • LeGallo R.D.
        • et al.
        Morphology in conjunction with immunohistochemistry is sufficient for the diagnosis of mammary analogue secretory carcinoma.
        Head Neck Pathol. 2015; 9: 85-95
        • Skalova A.
        Mammary analogue secretory carcinoma of salivary gland origin: an update and expanded morphologic and immunohistochemical spectrum of recently described entity.
        Head Neck Pathol. 2013; 7: S30-S36
        • Patel K.R.
        • Solomon I.H.
        • El-Mofty S.K.
        • et al.
        Mammaglobin and S-100 immunoreactivity in salivary gland carcinomas other than mammary analogue secretory carcinoma.
        Hum Pathol. 2013; 44: 2501-2508
        • Chênevert J.
        • Duvvuri U.
        • Chiosea S.
        • et al.
        DOG1: a novel marker of salivary acinar and intercalated duct differentiation.
        Mod Pathol. 2012; 25: 919-929
        • Liegl B.
        • Hornick J.L.
        • Corless C.L.
        • et al.
        Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes.
        Am J Surg Pathol. 2009; 33: 437-446
        • Miettinen M.
        • Wang Z.F.
        • Lasota J.
        DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases.
        Am J Surg Pathol. 2009; 33: 1401-1408
        • Novelli M.
        • Rossi S.
        • Rodriguez-Justo M.
        • et al.
        DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours.
        Histopathology. 2010; 57: 259-270
        • Urano M.
        • Nagao T.
        • Miyabe S.
        • et al.
        Characterization of mammary analogue secretory carcinoma of the salivary gland: discrimination from its mimics by the presence of the ETV6-NTRK3 translocation and novel surrogate markers.
        Hum Pathol. 2015; 46: 94-103
        • Caputo A.
        • Caci E.
        • Ferrera L.
        • et al.
        TMEM16 A, a membrane protein associated with calcium-dependent chloride channel activity.
        Science. 2008; 322: 590-594
        • Schroeder B.C.
        • Cheng T.
        • Jan Y.N.
        • et al.
        Expression cloning of TMEM16 A as a calcium-activated chloride channel subunit.
        Cell. 2008; 134: 1019-1029
        • Yang Y.D.
        • Cho H.
        • Koo J.Y.
        • et al.
        TMEM16 A confers receptor-activated calcium-dependent chloride conductance.
        Nature. 2008; 455: 1210-1215
        • Griffith C.C.
        • Stelow E.B.
        • Saqi A.
        • et al.
        The cytological features of mammary analogue secretory carcinoma: a series of 6 molecularly confirmed cases.
        Cancer Cytopathol. 2013; 121: 234-241
        • Tognon C.
        • Knezevich S.R.
        • Huntsman D.
        • et al.
        Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma.
        Cancer Cell. 2002; 2: 367-376
        • Bokemeyer A.
        • Eckert C.
        • Meyr F.
        • et al.
        Copy number genome alterations are associated with treatment response and outcome in relapsed childhood ETV6/RUNX1–positive acute lymphoblastic leukemia.
        Haematologica. 2014; 99: 706-714
        • Fonzar Hernandes M.A.
        • de Jesus Marques-Salles T.
        • Mkrtchyan H.
        • et al.
        Extra copies of der(21)t(12;21) plus deletion of ETV6 gene due to dic(12;18) in B-cell precursor ALL with poor outcome.
        Case Rep Genet. 2012; 2012: 1-4
        • Adem C.
        • Gisselsson D.
        • Dal Cin P.
        • et al.
        ETV6 rearrangements in patients with infantile fibrosarcomas and congenital mesoblasticnephromas by fluorescence in situ hybridization.
        Mod Pathol. 2001; 14: 1246-1251
        • Bishop J.A.
        • Yonescu R.
        • Batista D.
        • et al.
        Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma.
        Hum Pathol. 2013; 44: 1982-1988
        • Mariano F.V.
        • dos Santos H.T.
        • Azañero W.D.
        • et al.
        Mammary analogue secretory carcinoma of salivary glands is a lipid-rich tumour, and adipophilin can be valuable in its identification.
        Histopathology. 2013; 63: 558-567
        • Levine P.
        • Fried K.
        • Krevitt L.D.
        • et al.
        Aspiration biopsy of mammary analogue secretory carcinoma of accessory parotid gland: another diagnostic dilemma in matrix-containing tumors of the salivary glands.
        Diagn Cytopathol. 2014; 42: 49-53
        • Pisharodi L.
        Mammary analog secretory carcinoma of salivary gland: cytologic diagnosis and differential diagnosis of an unreported entity.
        Diagn Cytopathol. 2013; 41: 239-241
        • Hwang M.J.
        • Wu P.R.
        • Chen C.M.
        • et al.
        A rare malignancy of the parotid gland in a 13-year-old Taiwanese boy: case report of a mammary analogue secretory carcinoma of the salivary gland with molecular study.
        Med Mol Morphol. 2014; 47: 57-61
        • Chiosea S.I.
        • Griffith C.
        • Assaad A.
        • et al.
        Clinicopathological characterization of mammary analogue secretory carcinoma of salivary glands.
        Histopathology. 2012; 61: 387-394
        • Kratochvil 3rd, F.J.
        • Stewart J.C.
        • Moore S.R.
        Mammary analog secretory carcinoma of salivary glands: a report of 2 cases in the lips.
        Oral Surg Oral Med Oral Pathol Oral Radiol. 2012; 114: 630-635
        • Woo J.
        • Seethala R.R.
        • Sirintrapun S.J.
        Mammary analogue secretory carcinoma of the parotid gland as a secondary malignancy in a childhood survivor of atypical teratoid rhabdoid tumor.
        Head Neck Pathol. 2014; 8: 194-197
        • Connor A.
        • Perez-Ordoñez B.
        • Shago M.
        • et al.
        Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity.
        Am J Surg Pathol. 2012; 36: 27-34
        • Jung M.J.
        • Song J.S.
        • Kim S.Y.
        • et al.
        Finding and characterizing mammary analogue secretory carcinoma of the salivary gland.
        Korean J Pathol. 2013; 47: 36-43
        • Schwarz S.
        • Zenk J.
        • Müller M.
        • et al.
        The many faces of acinic cell carcinomas of the salivary glands: a study of 40 cases relating histological and immunohistological subtypes to clinical parameters and prognosis.
        Histopathology. 2012; 61: 395-408
        • Majewska H.
        • Skálová A.
        • Stodulski D.
        • et al.
        Mammary analogue secretory carcinoma of salivary glands: a new entity associated with ETV6 gene rearrangement.
        Virchows Arch. 2015; 466: 245-254
        • Griffith C.
        • Seethala R.
        • Chiosea S.I.
        Mammary analogue secretory carcinoma: a new twist to the diagnostic dilemma of zymogen granule poor acinic cell carcinoma.
        Virchows Arch. 2011; 459: 117-118
        • Quattlebaum S.C.
        • Roby B.
        • Dishop M.K.
        • et al.
        A pediatric case of mammary analogue secretory carcinoma within the parotid.
        Am J Otolaryngol. 2015; 36: 741-743
        • Rastatter J.C.
        • Jatana K.R.
        • Jennings L.J.
        • et al.
        Mammary analogue secretory carcinoma of the parotid gland in a pediatric patient.
        Otolaryngol Head Neck Surg. 2012; 146: 514-515
        • Skálová A.
        • Vanecek T.
        • Majewska H.
        • et al.
        Mammary analogue secretory carcinoma of salivary glands with high-grade transformation: report of 3 cases with the ETV6-NTRK3 gene fusion and analysis of TP53, â-catenin, EGFR, and CCND1 genes.
        Am J Surg Pathol. 2014; 38: 23-33
        • Hsieh M.S.
        • Jeng Y.M.
        • Jhuang Y.L.
        • et al.
        Carbonic anhydrase VI: a novel marker for salivary serous acinar differentiation and its application to discriminate acinic cell carcinoma from mammary analogue secretory carcinoma of the salivary gland.
        Histopathology. 2016; 68 (doi: 10.1111/his.12792.): 641-647
        • Ito Y.
        • Ishibashi K.
        • Masaki A.
        • et al.
        Mammary analogue secretory carcinoma of salivary glands: a clinicopathologic and molecular study including 2 cases harboring ETV6-X fusion.
        Am J Surg Pathol. 2015; 39: 602-610